Seven Researchers Guilty of Misconduct in Macchiarini Case

The Karolinska Institute’s latest decision includes a guilty verdict for one of the whistleblowers who contributed to the investigation.

Written byCatherine Offord
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Italian thoracic surgeon Paolo Macchiarini and six of his colleagues, one of whom was a whistleblower, have been found guilty of scientific misconduct in the latest investigation into the infamous researcher’s work by his former institution, the Karolinska Institute in Sweden. In a statement published yesterday (June 25), the Institute announced that an analysis of six articles published across four journals had discovered inaccuracies, misleading information, data fabrication, unjustified treatments, and a lack of appropriate ethical approvals. An additional 31 authors were deemed “blameworthy” for their contributions to the publications.

“This decision has been made after careful investigations in a case that has had major impact on Karolinska Institutet, on the scientific community at large, and on public confidence in medical research,” the Karolinska Institute’s president, Ole Petter Ottersen, says in the statement. “In particular, the case has had tragic consequences for patients and their relatives, for which I am ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies